Financials
- Market Capitalization 11.35 B
- Employee 3 000
- Founded 1976
- CEO Charles R. Kummeth
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
60.91
Fiyat/satışlar oranı
9.13
Hisse başına temettü
0.32
Temettü getirisi %
0.45
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 823 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.91 USD | -4.15% | -2.14% | -2.32% | +117.16% | 11.99 B USD | ||
| 826 | HALO Halozyme Therapeutics, Inc. - Common Stock | 105.35 USD | -1.47% | -2.53% | +26.64% | +57.71% | 11.96 B USD | ||
| 870 | SMMT Summit Therapeutics Inc. - Common Stock | 13.73 USD | -4.19% | +5.05% | +2.16% | -30.87% | 10.95 B USD | ||
| 890 | AXSM Axsome Therapeutics, Inc. - Common Stock | 199.02 USD | -3.51% | -3.86% | -15.12% | +52.86% | 10.42 B USD |